https://www.selleckchem.com/products/kpt-9274.html
8 months [95% confidence interval (CI) 22.8-29.8 months] in low risk patients (n= 128), 17.0 months (95% CI 15.0-24.0 months) in medium risk (n= 162) and 8.9 months (95% CI 8.0-10.7 months) in high risk (n= 114); low risk hazard ratio (HR) 1 (reference group), medium risk HR 1.95 (95% CI 1.38-2.74), high risk HR 4.84 (95% CI 3.16-7.43); P 0.0001. The LEP index was validated in a cohort of 127 Italian patients treated with lenvatinib. While the same classification did not show a prognostic value in a cohort of 311 patients treated
Like
Comment
Share
